Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M. N. Khagazheeva"'
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 157-162 (2022)
HCC is considered refractory when it comes to progression during treatment with TKIs (sorafenib, lenvatinib). The combined immunotherapy of nivolumab with ipilimumab was studied in the one cohort of CheckMate-040 study, excluding immunotherapy-naive
Externí odkaz:
https://doaj.org/article/88111f1fbbb34a1290aaebf398e8292a
Autor:
N. E. Kushlinskii, A. V. Snegovoy, N. V. Lyubimova, M N Khagazheeva, Yu A Nesterova, M. M. Dobrovolskaya, T. V. Davydova, Valentina Nikolaevna Blindar, G N Zubrikhina, I. B. Kononenko
Publikováno v:
Russian Clinical Laboratory Diagnostics. 66:147-153
A study of interleukin-6 (IL-6), hepcidin-25 (GP-25) was conducted in 22 patients with breast cancer before neoadjuvant chemotherapy and in 27 healthy women in the control group. Significant expression of the GP-25 protein was revealed in breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c690be43f81cde7b56c152a4cc3cfd1
https://doi.org/10.51620/0869-2084-2021-66-3-147-153
https://doi.org/10.51620/0869-2084-2021-66-3-147-153
Autor:
Valentina Nikolaevna Blindar, G. N. Zubrikhina, T. V. Davydova, M. M. Dobrovolskaya, M. N. Khagazheeva, A. V. Snegovoy, N. V. Lyubimova, N. E. Kushlinskii, D. A. Ryabchikov
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 67(4)
Early and adequate correction of the anemic syndrome (AS) of cancer patients can prevent deterioration in the quality of life and be considered as a reserve for increasing the effectiveness of treatment for breast cancer (BC). The aim of the study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c9526a2dc58bfb4f7663cec182cdf9
https://pubmed.ncbi.nlm.nih.gov/35575394
https://pubmed.ncbi.nlm.nih.gov/35575394
Autor:
D. A. Ryabchikov, F. K. Berdova, M. S. Vinokurov, I. K. Vorotnikov, O. A. Talipov, S. V. Chulkova, M. N. Khagazheeva, A. V. Snegovoy, A. M. Kazakov, V. I. Loginov
Publikováno v:
Medical alphabet. :12-15
This article discusses the mechanisms of the influence of microRNAs on carcinogenesis in breast cancer (breast cancer), their potential role as markers for the early detection, prognosis and effectiveness of breast cancer treatment. Epigenetic mechan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::319a0dd09179e55be5725d3db7a4f448
https://doi.org/10.33667/2078-5631-2020-8-12-15
https://doi.org/10.33667/2078-5631-2020-8-12-15
Autor:
Valentina Nikolaevna, Blindar, M M, Dobrovolskaya, M N, Khagazheeva, G N, Zubrikhina, Yu A, Nesterova, T V, Davydova, N V, Lyubimova, N E, Kushlinskii, I B, Kononenko, A V, Snegovoy
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 66(3)
A study of interleukin-6 (IL-6), hepcidin-25 (GP-25) was conducted in 22 patients with breast cancer before neoadjuvant chemotherapy and in 27 healthy women in the control group. Significant expression of the GP-25 protein was revealed in breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19b25a05d143a64f3d603797f17133d0
https://pubmed.ncbi.nlm.nih.gov/33793113
https://pubmed.ncbi.nlm.nih.gov/33793113